Implementation and outcome of minor and major minimally invasive liver surgery in the Netherlands.


Journal

HPB : the official journal of the International Hepato Pancreato Biliary Association
ISSN: 1477-2574
Titre abrégé: HPB (Oxford)
Pays: England
ID NLM: 100900921

Informations de publication

Date de publication:
12 2019
Historique:
received: 28 01 2019
revised: 25 04 2019
accepted: 07 05 2019
pubmed: 27 6 2019
medline: 15 7 2020
entrez: 26 6 2019
Statut: ppublish

Résumé

While most of the evidence on minimally invasive liver surgery (MILS) is derived from expert centers, nationwide outcomes remain underreported. This study aimed to evaluate the implementation and outcome of MILS on a nationwide scale. Electronic patient files were reviewed in all Dutch liver surgery centers and all patients undergoing MILS between 2011 and 2016 were selected. Operative outcomes were stratified based on extent of the resection and annual MILS volume. Overall, 6951 liver resections were included, with a median annual volume of 50 resections per center. The overall use of MILS was 13% (n = 916), which varied from 3% to 36% (P < 0.001) between centers. The nationwide use of MILS increased from 6% in 2011 to 23% in 2016 (P < 0.001). Outcomes of minor MILS were comparable with international studies (conversion 0-13%, mortality <1%). In centers which performed ≥20 MILS annually, major MILS was associated with less conversions (14 (11%) versus 41 (30%), P < 0.001), shorter operating time (184 (117-239) versus 200 (139-308) minutes, P = 0.010), and less overall complications (37 (30%) versus 58 (42%), P = 0.040). The nationwide use of MILS is increasing, although large variation remains between centers. Outcomes of major MILS are better in centers with higher volumes.

Sections du résumé

BACKGROUND
While most of the evidence on minimally invasive liver surgery (MILS) is derived from expert centers, nationwide outcomes remain underreported. This study aimed to evaluate the implementation and outcome of MILS on a nationwide scale.
METHODS
Electronic patient files were reviewed in all Dutch liver surgery centers and all patients undergoing MILS between 2011 and 2016 were selected. Operative outcomes were stratified based on extent of the resection and annual MILS volume.
RESULTS
Overall, 6951 liver resections were included, with a median annual volume of 50 resections per center. The overall use of MILS was 13% (n = 916), which varied from 3% to 36% (P < 0.001) between centers. The nationwide use of MILS increased from 6% in 2011 to 23% in 2016 (P < 0.001). Outcomes of minor MILS were comparable with international studies (conversion 0-13%, mortality <1%). In centers which performed ≥20 MILS annually, major MILS was associated with less conversions (14 (11%) versus 41 (30%), P < 0.001), shorter operating time (184 (117-239) versus 200 (139-308) minutes, P = 0.010), and less overall complications (37 (30%) versus 58 (42%), P = 0.040).
CONCLUSION
The nationwide use of MILS is increasing, although large variation remains between centers. Outcomes of major MILS are better in centers with higher volumes.

Identifiants

pubmed: 31235430
pii: S1365-182X(19)30540-4
doi: 10.1016/j.hpb.2019.05.002
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1734-1743

Investigateurs

Babs Zonderhuis (B)
Inne B Rinkes (IB)
Christiaan Hoff (C)
Steven Oosterling (S)

Informations de copyright

Copyright © 2019 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Auteurs

Marcel J van der Poel (MJ)

Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, the Netherlands.

Robert S Fichtinger (RS)

Department of Surgery, Maastricht University Medical Center+, Maastricht, the Netherlands; RWTH Aachen, Germany.

Marc Bemelmans (M)

Department of Surgery, Maastricht University Medical Center+, Maastricht, the Netherlands; RWTH Aachen, Germany.

Koop Bosscha (K)

Department of Surgery, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands.

Andries E Braat (AE)

Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.

Marieke T de Boer (MT)

Department of Surgery, University Medical Center Groningen, Groningen, the Netherlands.

Cornelis H C Dejong (CHC)

Department of Surgery, Maastricht University Medical Center+, Maastricht, the Netherlands; RWTH Aachen, Germany.

Pascal G Doornebosch (PG)

Department of Surgery, IJsselland Hospital, Capelle aan den IJssel, the Netherlands.

Werner A Draaisma (WA)

Department of Surgery, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands; Department of Surgery, Meander Medical Center, Amersfoort, the Netherlands.

Michael F Gerhards (MF)

Department of Surgery, OLVG, Amsterdam, the Netherlands.

Paul D Gobardhan (PD)

Department of Surgery, Amphia Hospital, Breda, the Netherlands.

Burak Gorgec (B)

Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, the Netherlands.

Jeroen Hagendoorn (J)

Department of Surgery, University Medical Center Utrecht, Utrecht, the Netherlands.

Geert Kazemier (G)

Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands.

Joost Klaase (J)

Department of Surgery, University Medical Center Groningen, Groningen, the Netherlands; Department of Surgery, Medical Spectrum Twente, Enschede, the Netherlands.

Wouter K G Leclercq (WKG)

Department of Surgery, Máxima Medical Center, Veldhoven, the Netherlands.

Mike S Liem (MS)

Department of Surgery, Medical Spectrum Twente, Enschede, the Netherlands.

Daan J Lips (DJ)

Department of Surgery, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands; Department of Surgery, Medical Spectrum Twente, Enschede, the Netherlands.

Hendrik A Marsman (HA)

Department of Surgery, OLVG, Amsterdam, the Netherlands.

J Sven D Mieog (JSD)

Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.

Quintus I Molenaar (QI)

Department of Surgery, University Medical Center Utrecht, Utrecht, the Netherlands.

Vincent B Nieuwenhuijs (VB)

Department of Surgery, Isala, Zwolle, the Netherlands.

Carolijn L Nota (CL)

Department of Surgery, University Medical Center Utrecht, Utrecht, the Netherlands.

Gijs A Patijn (GA)

Department of Surgery, Isala, Zwolle, the Netherlands.

Arjen M Rijken (AM)

Department of Surgery, Amphia Hospital, Breda, the Netherlands.

Gerrit D Slooter (GD)

Department of Surgery, Máxima Medical Center, Veldhoven, the Netherlands.

Martijn W J Stommel (MWJ)

Department of Surgery, Radboud University Medical Center, Nijmegen, the Netherlands.

Rutger-Jan Swijnenburg (RJ)

Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, the Netherlands; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.

Pieter J Tanis (PJ)

Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, the Netherlands.

Wouter W Te Riele (WW)

Department of Surgery, St. Antonius Hospital, Nieuwegein, the Netherlands.

Türkan Terkivatan (T)

Department of Surgery, Erasmus Medical Center, Rotterdam, the Netherlands.

Petrousjka M van den Tol (PM)

Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands.

Peter B van den Boezem (PB)

Department of Surgery, Radboud University Medical Center, Nijmegen, the Netherlands.

Joost A van der Hoeven (JA)

Department of Surgery, Albert Schweitzer Hospital, Dordrecht, the Netherlands.

Maarten Vermaas (M)

Department of Surgery, IJsselland Hospital, Capelle aan den IJssel, the Netherlands.

Moh'd Abu Hilal (M)

Department of Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Ronald M van Dam (RM)

Department of Surgery, Maastricht University Medical Center+, Maastricht, the Netherlands; RWTH Aachen, Germany.

Marc G Besselink (MG)

Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, the Netherlands. Electronic address: m.g.besselink@amc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH